{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T03:20:46Z","timestamp":1790911246922,"version":"4.1.0"},"reference-count":42,"publisher":"American Society of Hematology","issue":"10","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2005,5,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Burkitt lymphoma (BL) is a highly aggressive B-cell neoplasm harboring chromosomal rearrangements of the c-myc oncogene. BL cells frequently resist apoptosis induction by chemotherapeutic agents; however, the mechanism of unresponsiveness has not been elucidated. Here, we show that cytochrome c fails to stimulate apoptosome formation and caspase activation in cytosolic extracts of human BL-derived cell lines, due to insufficient levels of apoptotic protease-activating factor-1 (Apaf-1). Enforced expression of Apaf-1 increased its concentration in the cytosolic compartment, restored cytochrome c-dependent caspase activation, and rendered the prototypic Raji BL cell line sensitive to etoposide- and staurosporine-induced apoptosis. Surprisingly, in nontransfected BL cells, the bulk of Apaf-1 was found to associate with discrete domains in the plasma membrane. Disruption of lipid raft domains or the actin cytoskeleton of Raji cells liberated Apaf-1 and restored sensitivity to cytochrome c\u2013dependent apoptosis, indicating that constitutive Apaf-1 retained its ability to promote caspase activation. Moreover, disruption of lipid rafts sensitized BL cells to apoptosis induced by etoposide. Together, our findings suggest that ectopic (noncytosolic) localization of Apaf-1 may constitute a novel mechanism of chemoresistance in B lymphoma.<\/jats:p>","DOI":"10.1182\/blood-2004-10-4075","type":"journal-article","created":{"date-parts":[[2005,2,4]],"date-time":"2005-02-04T01:34:48Z","timestamp":1107480888000},"page":"4070-4077","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":38,"title":["Plasma membrane sequestration of apoptotic protease-activating factor-1 in human B-lymphoma cells: a novel mechanism of chemoresistance"],"prefix":"10.1182","volume":"105","author":[{"given":"Yu","family":"Sun","sequence":"first","affiliation":[{"name":"From the Division of Toxicology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden; the Division of Molecular Toxicology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden; and the Department of Physiology, National University of Singapore, Singapore."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sten","family":"Orrenius","sequence":"additional","affiliation":[{"name":"From the Division of Toxicology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden; the Division of Molecular Toxicology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden; and the Department of Physiology, National University of Singapore, Singapore."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shazib","family":"Pervaiz","sequence":"additional","affiliation":[{"name":"From the Division of Toxicology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden; the Division of Molecular Toxicology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden; and the Department of Physiology, National University of Singapore, Singapore."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bengt","family":"Fadeel","sequence":"additional","affiliation":[{"name":"From the Division of Toxicology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden; the Division of Molecular Toxicology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden; and the Department of Physiology, National University of Singapore, Singapore."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2020021218100707500_REF1","doi-asserted-by":"crossref","unstructured":"Hanahan D, Weinberg RA. The hallmarks of cancer. Cell. 2000;100: 57-70.","DOI":"10.1016\/S0092-8674(00)81683-9"},{"key":"2020021218100707500_REF2","doi-asserted-by":"crossref","unstructured":"Kaufmann SH, Vaux DL. Alterations in the apoptotic machinery and their potential role in anti-cancer drug resistance. Oncogene. 2003;22: 7414-7430.","DOI":"10.1038\/sj.onc.1206945"},{"key":"2020021218100707500_REF3","doi-asserted-by":"crossref","unstructured":"Danial NN, Korsmeyer SJ. Cell death: critical control points. Cell. 2004;116: 205-219.","DOI":"10.1016\/S0092-8674(04)00046-7"},{"key":"2020021218100707500_REF4","doi-asserted-by":"crossref","unstructured":"Soengas MS, Capodieci P, Polsky D, et al. Inactivation of the apoptosis effector Apaf-1 in malignant melanoma. Nature. 2001;409: 207-211.","DOI":"10.1038\/35051606"},{"key":"2020021218100707500_REF5","doi-asserted-by":"crossref","unstructured":"Jia L, Srinivasula SM, Liu FT, et al. Apaf-1 protein deficiency confers resistance to cytochrome c-dependent apoptosis in human leukemic cells. Blood. 2001;98: 414-421.","DOI":"10.1182\/blood.V98.2.414"},{"key":"2020021218100707500_REF6","doi-asserted-by":"crossref","unstructured":"Fu WN, Bertoni F, Kelsey SM, et al. Role of DNA methylation in the suppression of Apaf-1 protein in human leukaemia. Oncogene. 2003;22: 451-455.","DOI":"10.1038\/sj.onc.1206147"},{"key":"2020021218100707500_REF7","doi-asserted-by":"crossref","unstructured":"Wolf BB, Schuler M, Li W, et al. Defective cytochrome c-dependent caspase activation in ovarian cancer cell lines due to diminished or absent apoptotic protease activating factor-1 activity. J Biol Chem.2001;276: 34244-34251.","DOI":"10.1074\/jbc.M011778200"},{"key":"2020021218100707500_REF8","unstructured":"Liu JR, Opipari AW, Tan L, et al. Dysfunctional apoptosome activation in ovarian cancer: implications for chemoresistance. Cancer Res.2002;62: 924-931."},{"key":"2020021218100707500_REF9","doi-asserted-by":"crossref","unstructured":"Burgess DH, Svensson M, Dandrea T, et al. Human skeletal muscle cytosols are refractory to cytochrome c-dependent activation of type II caspases and lack Apaf-1. Cell Death Diff.1999; 6: 256-261.","DOI":"10.1038\/sj.cdd.4400489"},{"key":"2020021218100707500_REF10","doi-asserted-by":"crossref","unstructured":"Pandey P, Saleh A, Nakazawa A, et al. Negative regulation of cytochrome c-mediated oligomerization of Apaf-1 and activation of procaspase-9 by heat shock protein 90. EMBO J.2000;19: 4310-4322.","DOI":"10.1093\/emboj\/19.16.4310"},{"key":"2020021218100707500_REF11","doi-asserted-by":"crossref","unstructured":"Jiang X, Kim HE, Shu H, et al. Distinctive roles of PHAP proteins and prothymosin-\u03b1 in a death regulatory pathway. Science. 2003;299: 223-226.","DOI":"10.1126\/science.1076807"},{"key":"2020021218100707500_REF12","doi-asserted-by":"crossref","unstructured":"Park SE, Kim ND, Yoo YH. Acetylcholinesterase plays a pivotal role in apoptosome formation. Cancer Res.2004;64: 2652-2655.","DOI":"10.1158\/0008-5472.CAN-04-0649"},{"key":"2020021218100707500_REF13","doi-asserted-by":"crossref","unstructured":"Hecht JL, Aster JC. Molecular biology of Burkitt's lymphoma. J Clin Oncol.2000;18: 3707-3721.","DOI":"10.1200\/JCO.2000.18.21.3707"},{"key":"2020021218100707500_REF14","doi-asserted-by":"crossref","unstructured":"Gaidano G, Ballerini P, Gong JZ, et al. p53 mutations in human lymphoid malignancies: association with Burkitt lymphoma and chronic lymphocytic leukemia. Proc Natl Acad Sci U S A.1991; 88: 5413-5417.","DOI":"10.1073\/pnas.88.12.5413"},{"key":"2020021218100707500_REF15","unstructured":"Corn PG, Kuerbitz SJ, van Noesel MM, et al. Transcriptional silencing of the p73 gene in acute lymphoblastic leukemia and Burkitt's lymphoma is associated with 5\u2032 CpG island methylation. Cancer Res.1999;59: 3352-3356."},{"key":"2020021218100707500_REF16","doi-asserted-by":"crossref","unstructured":"Gavioli R, Frisan T, Vertuani S, Bornkamm GW, Masucci MG. c-myc overexpression activates alternative pathways for intracellular proteolysis in lymphoma cells. Nat Cell Biol.2001;3: 283-288.","DOI":"10.1038\/35060076"},{"key":"2020021218100707500_REF17","doi-asserted-by":"crossref","unstructured":"Kawabata Y, Hirokawa M, Kitabayashi A, Horiuchi T, Kuroki J, Miura AB. Defective apoptotic signal transduction pathway downstream of caspase-3 in human B lymphoma cells: a novel mechanism of nuclear apoptosis resistance. Blood. 1999;94: 3523-3530.","DOI":"10.1182\/blood.V94.10.3523.422k07_3523_3530"},{"key":"2020021218100707500_REF18","doi-asserted-by":"crossref","unstructured":"Zhao EG, Song Q, Cross S, Misko I, Lees-Miller SP, Lavin MF. Resistance to etoposide-induced apoptosis in a Burkitt's lymphoma cell line. Int J Cancer. 1998;77: 755-762.","DOI":"10.1002\/(SICI)1097-0215(19980831)77:5<755::AID-IJC15>3.0.CO;2-0"},{"key":"2020021218100707500_REF19","doi-asserted-by":"crossref","unstructured":"Ahmad KA, Clement MV, Hanif IM, Pervaiz S. Resveratrol inhibits drug-induced apoptosis in human leukemia cells by creating an intracellular milieu nonpermissive for death execution. Cancer Res.2004;64: 1452-1459.","DOI":"10.1158\/0008-5472.CAN-03-2414"},{"key":"2020021218100707500_REF20","doi-asserted-by":"crossref","unstructured":"Zhang X, Uthaisang W, Hu LF, Ernberg IT, Fadeel B. Epstein-Barr virus-encoded latent membrane protein 1 promotes stress-induced apoptosis upstream of caspase-2-dependent mitochondrial perturbation. Int J Cancer. 2005;113: 397-405.","DOI":"10.1002\/ijc.20553"},{"key":"2020021218100707500_REF21","doi-asserted-by":"crossref","unstructured":"Fadeel B, A\u030ahlin A, Henter J-I, Orrenius S, Hampton MB. Involvement of caspases in neutrophil apoptosis: regulation by reactive oxygen species. Blood. 1998;92: 4808-4818.","DOI":"10.1182\/blood.V92.12.4808"},{"key":"2020021218100707500_REF22","doi-asserted-by":"crossref","unstructured":"Hirpara JL, Seyed MA, Loh KW, Dong H, Kini RM, Pervaiz S. Induction of mitochondrial permeability transition and cytochrome c release in the absence of caspase activation is insufficient for effective apoptosis in human leukemia cells. Blood. 2000;95: 1773-1780.","DOI":"10.1182\/blood.V95.5.1773.005k17_1773_1780"},{"key":"2020021218100707500_REF23","doi-asserted-by":"crossref","unstructured":"Chandra J, Mansson E, Gogvadze V, Kaufmann SH, Albertioni F, Orrenius S. Resistance of leukemic cells to 2-chlorodeoxyadenosine is due to a lack of calcium-dependent cytochrome c release. Blood. 2002;99: 655-663.","DOI":"10.1182\/blood.V99.2.655"},{"key":"2020021218100707500_REF24","doi-asserted-by":"crossref","unstructured":"Zou H, Henzel WJ, Liu X, Lutschg A, Wang X. Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of caspase-3. Cell. 1997;90: 405-413.","DOI":"10.1016\/S0092-8674(00)80501-2"},{"key":"2020021218100707500_REF25","unstructured":"Kuroki J, Hirokawa M, Kitabayashi A, et al. Cell-permeable ceramide inhibits the growth of B lymphoma Raji cells lacking TNF-\u03b1-receptors by inducing G0\/G1 arrest but not apoptosis: a new model for dissecting cell cycle arrest and apoptosis. Leukemia. 1996;10: 1950-1958."},{"key":"2020021218100707500_REF26","doi-asserted-by":"crossref","unstructured":"Robertson JD, Gogvadze V, Zhivotovsky B, Orrenius S. Distinct pathways for stimulation of cytochrome c release by etoposide. J Biol Chem.2000;275: 32438-32443.","DOI":"10.1074\/jbc.C000518200"},{"key":"2020021218100707500_REF27","doi-asserted-by":"crossref","unstructured":"Karpova MB, Schoumans J, Ernberg I, Henter J-I, Nordenskjo\u0308ld M, Fadeel B. Raji revisited: cytogenetics of the original Burkitt's lymphoma cell line. Leukemia. 2005;19: 159-161.","DOI":"10.1038\/sj.leu.2403534"},{"key":"2020021218100707500_REF28","doi-asserted-by":"crossref","unstructured":"Goping IS, Barry M, Liston P, et al. Granzyme B-induced apoptosis requires both direct caspase activation and relief of caspase inhibition. Immunity. 2003;18: 355-365.","DOI":"10.1016\/S1074-7613(03)00032-3"},{"key":"2020021218100707500_REF29","doi-asserted-by":"crossref","unstructured":"Benedict MA, Hu Y, Inohara N, Nunez G. Expression and functional analysis of Apaf-1 isoforms. Extra WD40 repeat is required for cytochrome c binding and regulated activation of procaspase-9. J Biol Chem.2000;275: 8461-8468.","DOI":"10.1074\/jbc.275.12.8461"},{"key":"2020021218100707500_REF30","doi-asserted-by":"crossref","unstructured":"Acehan D, Jiang X, Morgan DG, Heuser JE, Wang X, Akey CW. Three-dimensional structure of the apoptosome: implications for assembly, procaspase-9 binding, and activation. Mol Cell.2002;9: 423-432.","DOI":"10.1016\/S1097-2765(02)00442-2"},{"key":"2020021218100707500_REF31","doi-asserted-by":"crossref","unstructured":"Samali A, Cai J, Zhivotovsky B, Jones DP, Orrenius S. Presence of a pre-apoptotic complex of pro-caspase-3, Hsp60 and Hsp10 in the mitochondrial fraction of Jurkat cells. EMBO J.1999; 18: 2040-2048.","DOI":"10.1093\/emboj\/18.8.2040"},{"key":"2020021218100707500_REF32","doi-asserted-by":"crossref","unstructured":"Hausmann G, O'Reilly LA, van Driel R, et al. Proapoptotic apoptosis protease-activating factor 1 (Apaf-1) has a cytoplasmic localization distinct from Bcl-2 or Bcl-XL. J Cell Biol.2000;149: 623-634.","DOI":"10.1083\/jcb.149.3.623"},{"key":"2020021218100707500_REF33","doi-asserted-by":"crossref","unstructured":"Ruiz-Vela A, Albar JP, Martinez CA. Apaf-1 localization is modulated indirectly by Bcl-2 expression. FEBS Lett.2001;501: 79-83.","DOI":"10.1016\/S0014-5793(01)02629-1"},{"key":"2020021218100707500_REF34","doi-asserted-by":"crossref","unstructured":"Simons K, Toomre D. Lipid rafts and signal transduction. Nat Rev Mol Cell Biol.2000;1: 31-39.","DOI":"10.1038\/35036052"},{"key":"2020021218100707500_REF35","doi-asserted-by":"crossref","unstructured":"Oliferenko S, Paiha K, Harder T, et al. Analysis of CD44-containing lipid rafts: recruitment of annexin II and stabilization by the actin cytoskeleton. J Cell Biol.1999;146: 843-854.","DOI":"10.1083\/jcb.146.4.843"},{"key":"2020021218100707500_REF36","doi-asserted-by":"crossref","unstructured":"Blum KA, Lozanski G, Byrd JC. Adult Burkitt's leukemia and lymphoma. Blood. 2004;104: 3009-3020.","DOI":"10.1182\/blood-2004-02-0405"},{"key":"2020021218100707500_REF37","doi-asserted-by":"crossref","unstructured":"Kashkar H, Haefs C, Shin H, et al. XIAP-mediated caspase inhibition in Hodgkin's lymphoma-derived B cells. J Exp Med.2003;198: 341-347.","DOI":"10.1084\/jem.20021279"},{"key":"2020021218100707500_REF38","doi-asserted-by":"crossref","unstructured":"Ayllon V, Fleischer A, Cayla X, Garcia A, Rebollo A. Segregation of Bad from lipid rafts is implicated in the induction of apoptosis. J Immunol.2002;168: 3387-3393.","DOI":"10.4049\/jimmunol.168.7.3387"},{"key":"2020021218100707500_REF39","doi-asserted-by":"crossref","unstructured":"Puthalakath H, Huang DC, O'Reilly LA, King SM, Strasser A. The proapoptotic activity of the Bcl-2 family member Bim is regulated by interaction with the dynein motor complex. Mol Cell.1999;3: 287-296.","DOI":"10.1016\/S1097-2765(00)80456-6"},{"key":"2020021218100707500_REF40","doi-asserted-by":"crossref","unstructured":"Chen F, Hersh BM, Conradt B, et al. Translocation of C. elegans CED-4 to nuclear membranes during programmed cell death. Science. 2000; 287: 1485-1489.","DOI":"10.1126\/science.287.5457.1485"},{"key":"2020021218100707500_REF41","doi-asserted-by":"crossref","unstructured":"Nguyen JT, Wells JA. Direct activation of the apoptosis machinery as a mechanism to target cancer cells. Proc Natl Acad Sci U S A.2003;100: 7533-7538.","DOI":"10.1073\/pnas.1031631100"},{"key":"2020021218100707500_REF42","doi-asserted-by":"crossref","unstructured":"Lauber K, Appel HA, Schlosser SF, Gregor M, Schulze-Osthoff K, Wesselborg S. The adapter protein apoptotic protease-activating factor-1 (Apaf-1) is proteolytically processed during apoptosis. J Biol Chem.2001;276: 29772-29781.","DOI":"10.1074\/jbc.M101524200"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/105\/10\/4070\/1709074\/zh801005004070.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/105\/10\/4070\/1709074\/zh801005004070.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,13]],"date-time":"2020-02-13T00:18:07Z","timestamp":1581553087000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/105\/10\/4070\/19956\/Plasma-membrane-sequestration-of-apoptotic"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,5,15]]},"references-count":42,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2005,5,15]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2004-10-4075","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,5,15]]}}}